Importantly, the apoptotic effect of this combination was shown to be independent of the mutational status of the p53 gene and the levels of expression of ERα, two factors that determine the sensitivity or resistance of breast cancer cells to apoptosis [15, 16]. Here, TP53 is linked to breast carcinoma.